This inventor holds 2 USPTO granted patents. Top assignees: Sangamo Therapeutics, Inc., University of Washington. Active years: 2018-2020.
Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile
Company Filing History:
2 out of 155 
2 out of 2,173 
Years Active: 2018-2020
Title: Jeff Vierstra: Innovator in Genome Engineering
Introduction
Jeff Vierstra is a prominent inventor based in Seattle, WA, known for his contributions to the field of genome engineering. With a total of two patents to his name, he has made significant strides in the targeted modification of genetic material.
Latest Patents
His latest patents include "Nuclease-mediated regulation of gene expression," which focuses on the targeted modification of the genome of hematopoietic cells. This innovative approach has the potential to revolutionize gene therapy and enhance our understanding of genetic regulation.
Career Highlights
Throughout his career, Jeff has worked with notable organizations such as Sangamo Therapeutics, Inc. and the University of Washington. His work in these institutions has allowed him to explore and develop groundbreaking techniques in genome engineering.
Collaborations
Jeff has collaborated with esteemed colleagues, including Andreas Reik and John A Stamatoyannopoulos, further enriching his research and contributions to the field.
Conclusion
In summary, Jeff Vierstra is a key figure in genome engineering, with innovative patents that pave the way for advancements in genetic modification. His work continues to impact the scientific community and holds promise for future developments in gene therapy.
Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile